Malignant hypertension: a type of IgA nephropathy manifestation with poor prognosis Ángel M. Sevillano-Prieto, Ángel M. Sevillano, Jimena Cabrera-Betancor, Jimena Cabrera, Eduardo Gutiérrez-Martínez, Eduardo Gutiérrez, Enrique Morales-Ruiz, Enrique Morales, Evangelina Mérida-Herrero, Evangelina Mérida, Teresa Cavero-Escribano, Ana Huerta, Eduardo Hernández-Martínez, Teresa Cavero, Juan A. Moreno-Gutiérrez, Eduardo Hernández, Manuel Praga-Terente, Juan A. Moreno, Manuel Praga

The clinical impact of the physiological effects of erythropoietin and erythropoietin-stimulating agents on the incidence of malignancy, thrombosis and hypertension: Beyond anaemia Luis M Ortega, Gabriel Contreras

C1q Nephropathy and Malignancy Sofia Rocha, M. João Carvalho, Luísa Lobato, Josefina Santos, Guilherme Rocha, Ramón Vizcaíno, António Cabrita